Home
/
Treatment
/
cis-adamantane-2-spiro-3′-8′-[4′-[2′-(4′-morpholinyl)ethoxy]phenyl]-1′,2,’4′-trioxaspiro[4.5] decane mesylate

cis-adamantane-2-spiro-3′-8′-[4′-[2′-(4′-morpholinyl)ethoxy]phenyl]-1′,2,’4′-trioxaspiro[4.5] decane mesylate

	cis-adamantane-2-spiro-3′-8′-[4′-[2′-(4′-morpholinyl)ethoxy]phenyl]-1′,2,’4′-trioxaspiro[4.5] decane mesylate
Trade Name
Orphan Indication	Malaria
USA Market Approval	USA
USA Designation Date	2010-01-19 00:00:00
Sponsor	Medicines for Malaria Venture (MMV);International Centre Cointrin, P. O. Box 1826;CH-1215 Geneva 15